Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-α

Circulation

Volumn 99, Issue 3, 1999, Pages 448-454

  Franco, Fatima ^a   Thomas, Gail D ^a   Giroir, Brett ^a   Bryant, Debora ^a   Bullock, M Craig ^b   Chwialkowski, Michael C ^b   Victor, Ronald G ^a   Peshock, Ronald M ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b University of Texas   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Cardiac output; Heart failure; Magnetic resonance imaging; Systole

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART OUTPUT; IMAGE ANALYSIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0032890967     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.3.448     Document Type: Article

References (37)

1. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;318:1481-1486.
2. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 1996;347:1151-1155.
3. Kapadia S, Lee JR, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest. 1995;96: 1042-1052.
4. Giroir BP, Johnson JH, Brown T, Allen GL, Beutler B. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest. 1992;90:693-698.
5. Giroir BP, Horton JW, White DJ, McIntyre KL, Lin CQ. Inhibition of tumor necrosis factor (TNF) prevents myocardial dysfunction during burn shock. Am J Physiol. 1994;267:H118-H124.
6. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock RM, Thompson M, Giroir B. Cardiac failure in a transgenic mice with myocardial expression of tumor necrosis factor-α (TNF). Circulation. 1998; 97:1375-1381.
7. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Korestsky AP, Demetris AJ, Feldman AM. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α. Circ Res. 1997;81:627-635.
8. Peshock RM, Willet DL, Sayad DE, Hundley WG, Chwialkowski MC, Clarke GD, Parkey RW. Quantitative MR imaging of the heart. Magn Reson Imaging Clin N Am. 1996;4:287-305.
9. James JF, Hewett TE, Robbins J. Cardiac physiology in transgenic mice. Circ Res. 1998;82:407-415.
10. Franco F; Dubois S; Peshock RM; Shohet RV. Magnetic resonance imaging accurately estimates left ventricular mass in a transgenic mouse of cardiac hypertrophy. Am J Physiol. 1998;274 (Heart Circ Physiol. 43):H679-H683).
11. Franco F; Dubois S; Peshock RM; Shohet RV. Magnetic resonance imaging accurately estimates left ventricular mass in a transgenic mouse of cardiac hypertrophy. Am J Physiol. 1998;274 (Heart Circ Physiol. 43):H679-H683).
12. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
13. Laird NM, Ware JH. Random-effects for longitudinal data. Biometrics. 1982;38:963-974.
14. Hoit BD, Khoury SF, Kranias EG, Ball N, Walsh RA. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res. 1995;77: 632-637.
15. Gardin JM, Siri FM, Edwards JG, Leinwand LA. Echocardiographic assessment of left ventricular mass and systolic function in mice. Circ Res. 1995;76:907-914.
16. Schiller NB, Acquatella H, Ports TA, Drew D, Goerke J, Ringertz H, Silverman NH, Brundage B, Botvinik EH, Boswell R, Carlsson E, Parmley WW. Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation. 1979;60:547-555.
17. Taffet GE, Hartley CJ, Wen X, Pham T, Michael LH, Entman ML. Noninvasive indexes of cardiac systolic and diastolic function in hyperthyroid and senescent mouse. Am J Physiol. 1996;270 (Heart Circ Physiol. 39):H2204-H2209.
18. Taffet GE, Hartley CJ, Wen X, Pham T, Michael LH, Entman ML. Noninvasive indexes of cardiac systolic and diastolic function in hyperthyroid and senescent mouse. Am J Physiol. 1996;270 (Heart Circ Physiol. 39):H2204-H2209.
19. Rose SE, Wilson SJ, Zelaya FO, Crozier S, Doddrell DM. High resolution high field rodent cardiac imaging with flow enhancement suppression. Magn Reson Imaging. 1994;12:1183-1190.
20. Rehr RB, Malloy CR, Filipchuk NG, Peshock RM. Left ventricular volumes measured by MR imaging. Radiology. 1985;156:717-719.
21. Longmore DB, Underwood SR, Hounsfield GN, Bland C, Poole-Wilson PA, Denison D, Klipstein RH, Firmin DN, Watanabe M, Fox K, Rees RSO, McNeilly AM, Burman ED. Dimensional accuracy of magnetic resonance in studies of the heart. Lancet. 1985;1:1360-1362.
22. Hoit BD, Ball N, Walsh RA. Invasive hemodynamics and force-frequency relationships in open-versus closed-chest mice. Am J Physiol. 1997;273 (Heart Circ Physiol. 42):H2528-H2533.
23. Hoit BD, Ball N, Walsh RA. Invasive hemodynamics and force-frequency relationships in open-versus closed-chest mice. Am J Physiol. 1997;273 (Heart Circ Physiol. 42):H2528-H2533.
24. Barbee RW, Perry BD, Ré RN, Murgo JP. Microsphere and dilution techniques for the determination of blood flows and volumes in conscious mice. Am J Physiol. 1992;263:R728-R733.
25. Taylor SH. Measurement of the cardiac output in man. Proc R Soc Med. 1966;59:1-35.
26. Vogel J. Measurements of cardiac output in small laboratory animals using records of blood conductivity. Am J Physiol. 1997;273 (Heart Circ Physiol. 42):H2520-H2527.
27. Vogel J. Measurements of cardiac output in small laboratory animals using records of blood conductivity. Am J Physiol. 1997;273 (Heart Circ Physiol. 42):H2520-H2527.
28. Zukowska-Grojec Z, Marks ES, Haass M. Neuropeptide Y is a potent vasoconstrictor and a cardiodepressant in rat. Am J Physiol. 1987; 253 (Heart Circ Physiol. 22):H1234-H1239.
29. Zukowska-Grojec Z, Marks ES, Haass M. Neuropeptide Y is a potent vasoconstrictor and a cardiodepressant in rat. Am J Physiol. 1987; 253 (Heart Circ Physiol. 22):H1234-H1239.
30. Salyers AK, Rozek LF, Bittner SE, Walsh GM. Simultaneous determination of ventricular function and systemic hemodynamics in the conscious rat. J Pharmacol Methods. 1988;19:267-274.
31. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol. 1996;28:964-971.
32. Bozkurt B, Kribbs SB, Clubb FJ, Michael LH, Didenko VV, Hornsby PJ, Seta Y, Oral H, Spinale FG, Mann DL. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation. 1998;97: 1382-1392.
33. Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman M, Mann DL. Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes. Circulation. 1997;95:1247-1252.
34. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Man DL. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704-711.
35. Hayes BE, Will JA, Zarnstorff WC, Bisgard GE. Limitations of thermodilution cardiac output measurements in the rat. Am J Physiol. 1984; 246 (Heart Circ Physiol. 15):H754-H760.
36. Hayes BE, Will JA, Zarnstorff WC, Bisgard GE. Limitations of thermodilution cardiac output measurements in the rat. Am J Physiol. 1984; 246 (Heart Circ Physiol. 15):H754-H760.
37. Smith TL, Hutchins PM. Anesthetic effects on hemodynamics of spontaneously hypertensive and Wistar-Kyoto rats. Am J Physiol. 1980;238: H539-H544.